BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18337428)

  • 1. Fatigue in multiple sclerosis presenting as acute relapse: subjective and objective assessment.
    Flachenecker P; Meissner H
    Mult Scler; 2008 Mar; 14(2):274-7. PubMed ID: 18337428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of self-assessed fatigue and alertness in multiple sclerosis.
    Weinges-Evers N; Brandt AU; Bock M; Pfueller CF; Dörr J; Bellmann-Strobl J; Scherer P; Urbanek C; Boers C; Ohlraun S; Zipp F; Paul F
    Mult Scler; 2010 Sep; 16(9):1134-40. PubMed ID: 20610494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis associated fatigue during natalizumab treatment.
    Putzki N; Yaldizli O; Tettenborn B; Diener HC
    J Neurol Sci; 2009 Oct; 285(1-2):109-13. PubMed ID: 19560168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways.
    Sepulcre J; Masdeu JC; Goñi J; Arrondo G; Vélez de Mendizábal N; Bejarano B; Villoslada P
    Mult Scler; 2009 Mar; 15(3):337-44. PubMed ID: 18987107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premenstrual multiple sclerosis pseudoexacerbations: Role of body temperature and prevention with aspirin.
    Wingerchuk DM; Rodriguez M
    Arch Neurol; 2006 Jul; 63(7):1005-8. PubMed ID: 16831971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis.
    Morrow SA; Weinstock-Guttman B; Munschauer FE; Hojnacki D; Benedict RH
    Mult Scler; 2009 Aug; 15(8):998-1005. PubMed ID: 19667024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatigue and cognition in patients with relapsing multiple sclerosis treated with interferon β.
    Melanson M; Grossberndt A; Klowak M; Leong C; Frost EE; Prout M; Le Dorze JA; Gramlich C; Doupe M; Wong L; Esfahani F; Gomori A; Namaka M
    Int J Neurosci; 2010 Oct; 120(10):631-40. PubMed ID: 20942577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alexithymia in multiple sclerosis: relationship with fatigue and depression.
    Bodini B; Mandarelli G; Tomassini V; Tarsitani L; Pestalozza I; Gasperini C; Lenzi GL; Pancheri P; Pozzilli C
    Acta Neurol Scand; 2008 Jul; 118(1):18-23. PubMed ID: 18162056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinsonism as a manifestation of multiple sclerosis.
    Folgar S; Gatto EM; Raina G; Micheli F
    Mov Disord; 2003 Jan; 18(1):108-10. PubMed ID: 12518309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cognitive dysfunction as a hidden multiple sclerosis related symptom relevant for an expert appraisal].
    Kraus J; Lohmann H; Evers S
    Fortschr Neurol Psychiatr; 2009 Jan; 77(1):38-43. PubMed ID: 19101878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trajectory of fatigue severity in natalizumab treated multiple sclerosis patients.
    Yildiz M; Tettenborn B; Borgwardt S
    Clin Neurol Neurosurg; 2013 Jul; 115(7):902-3. PubMed ID: 23021201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial.
    Köpke S; Kasper J; Mühlhauser I; Nübling M; Heesen C
    Mult Scler; 2009 Jan; 15(1):96-104. PubMed ID: 18845657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis.
    Melamud L; Golan D; Luboshitzky R; Lavi I; Miller A
    J Neurol Sci; 2012 Mar; 314(1-2):37-40. PubMed ID: 22137446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open, uncontrolled, nonrandomized, 9-month, off-label use of bupropion to treat fatigue in a single patient with multiple sclerosis.
    Siniscalchi A; Gallelli L; Tolotta GA; Loiacono D; De Sarro G
    Clin Ther; 2010 Nov; 32(12):2030-4. PubMed ID: 21118738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological testing and event-related potentials in the assessment of cognitive performance in the patients with multiple sclerosis--a pilot study.
    Pokryszko-Dragan A; Zagrajek M; Slotwinski K; Gruszka E; Bilinska M; Podemski R
    Clin Neurol Neurosurg; 2009 Jul; 111(6):503-6. PubMed ID: 19233546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [General practitioners' approach to relapsing multiple sclerosis].
    Mackowiak A; Jamart V; Donze C; Hautecoeur P;
    Rev Neurol (Paris); 2003 Feb; 159(2):196-8. PubMed ID: 12660572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatigue, depression and progression in multiple sclerosis.
    Koch M; Uyttenboogaart M; van Harten A; Heerings M; De Keyser J
    Mult Scler; 2008 Jul; 14(6):815-22. PubMed ID: 18535019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of neuropsychological testing for guiding treatment decisions in paediatric multiple sclerosis.
    Penner IK; Hubacher M; Rasenack M; Sprenger T; Weber P; Naegelin Y
    Mult Scler; 2013 Mar; 19(3):366-8. PubMed ID: 22740487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive deficits in multiple sclerosis patients with cerebellar symptoms.
    Valentino P; Cerasa A; Chiriaco C; Nisticò R; Pirritano D; Gioia M; Lanza P; Canino M; Del Giudice F; Gallo O; Condino F; Torchia G; Quattrone A
    Mult Scler; 2009 Jul; 15(7):854-9. PubMed ID: 19542264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.